SELENOMETHIONINE SE 75
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Nov 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SELENOMETHIONINE SE 75 is a selenium-75 labeled radiopharmaceutical administered by injection for diagnostic imaging purposes. As a radioactive tracer, it targets selenium metabolism to visualize organ function and detect pathology. This product represents a niche diagnostic agent with specific imaging applications in nuclear medicine.
LOE Approaching
Legacy product nearing loss of exclusivity with minimal linked career opportunities and likely contracted team supporting this declining asset.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
This legacy diagnostic product offers minimal career advancement opportunity with zero linked job openings. Roles are primarily focused on compliance, manufacturing oversight, and regulatory maintenance rather than commercial growth or innovation.
Regulatory Affairs SpecialistManufacturing/Supply Chain Manager
Worked on SELENOMETHIONINE SE 75 at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.